Sunday, February 17, 2019

Immunotherapies could change kidney cancer care, studies suggest

Two studies showed that renal cell cancer patients had significantly better outcomes when their treatment combined the targeted therapy drug axitinib, or Inlyta, with an immunotherapy -- one study used pembrolizumab, or Keytruda, and the other used avelumab, or Bavencio.


from CNN.com - RSS Channel https://cnn.it/2tpK9ji
via

No comments:

Post a Comment